Pretransplant comorbidity as an outcome predictor in adult patients younger than 60 years of age receiving standard induction chemotherapy for de novo acute myeloid leukemia

S. Y. Kim,Junnam Lee,Duck-Woo Kim,Sung Nam Lim,Yun-Gyoo Lee,Y K Kang,Miee Seol,Sang-Young Ryu,Kyung Eun Lee

Pretransplant comorbidity as an outcome predictor in adult patients younger than 60 years of age receiving standard induction chemotherapy for de novo acute myeloid leukemia

2016

S. Y. Kim
Junnam Lee
Duck-Woo Kim
Sung Nam Lim
Yun-Gyoo Lee
Y K Kang
Miee Seol
Sang-Young Ryu
Kyung Eun Lee

7055 Background: Comorbidity has been evaluated as an outcome predictor in elderly patients receiving induction chemotherapy for acute myeloid leukemia (AML) as well as in patients undergoing allog...

Keywords:

Oncology
Myeloid leukemia
Pathology
Induction chemotherapy
Comorbidity
Medicine
Internal medicine
in patient
de novo acute
outcome predictor
adult patients

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations